Using the EHR for the identification of patients at high risk for hereditary breast and ovarian cancer. Brian Drohan University of Massachusetts 5/30/08.

Slides:



Advertisements
Similar presentations
How will you approach the 35 year old, with a 2 x 2 x 2cm, firm, mobile, well circumscribed non tender mass on the right breast?
Advertisements

Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.
Surgical Pathology of Wide Local Excision of Breast
Breast Pathology Helge Stalsberg MD University Hospital of North Norway.
MCQs On Breast Imaging:
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Breast Cancer By Kajal Haghmoradi.
Breast Neoplasm In this section we will be discussing breast neoplasm.
Breast Imaging Made Brief and Simple
Ductal Carcinoma in situ
Proliferative Epithelial lesions of the Breast
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
Breast Pathology Seminar CASE PRESENTATION PART 1 Elba Torres Matundan MD FCAP Victor Carlo Vargas MD FCAP.
ASSESSMENT OF BREAST SYMPTOMS/LUMPS Professor P Grantley Gill Specialists Without Borders Seminar in Surgery Rwanda, September 2010.
Elshami M.Elamin, MD Medical Oncologist Central Care Cancer Center Wichita, KS, USA
Breast Cancer Clinical Cases Daniel A. Nikcevich, MD, PhD SMDC Cancer Center April 20, 2009.
Nannozi Ssenkoloto, Program Manager October 8, 2013.
How are we doing? Quality in Breast Cancer Care Dr Michelle Goecke Surgical Oncology Network Update October 18, 2014.
BCT: Towards Optimal Outcomes
Marion C.W. Henry, MD Yale University
NYU Medical Grand Rounds Clinical Vignette Elizabeth Selden, MD PGY-2 November 8, 2011 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
HAT subcommittee for grossing standardization.  Brian Adley  Carey August  Rasheed Hammadeh  Mike Mihalov  Adaora Okonkwo.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Breast Cancer Steven Jones, MD. 2 Epidemiology of Breast Cancer 182,460 American women diagnosed each year. 40,480 die each year from the disease Lifetime.
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
Tutorial on Breast Pathology Part I: Ductal and Lobular Neoplasias Thomas J Lawton MD, Director Seattle Breast Pathology Consultants, LLC Seattle, WA.
Jump to first page First pregnancy after age 30 (RR 1.48). BMI >29 (RR 1.48). Being a college graduate, independent of OB-GYN history (RR 1.36). (Collaborative.
Atoosa Adibi MD. Department of Radiology Isfahan University Of Medical Sciences.
MedPix Medical Image Database COW - Case of the Week Case Contributor: Russell A. Patterson Affiliation: Uniformed Services University.
Imaging examinations of breasts
Ductal Carcinoma In Situ Shahla Masood, M.D. Professor of Pathology University of Florida College of Medicine - Jacksonville Chief of Pathology and Laboratory.
Introduction to Breast Imaging BREAST RAD LAB Directions: Please answer all the questions prior to interactive conference. 1.
Breast cancer -most common -Second common ( Death ) new case ( 2003 ) diagnosed - Lifetime Risk 2.5 % ( 1-8 )
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
IN THE NAME OF GOD BREAST DISEASE E.Naghshineh M.D.
Katie Ludwig FY1.   50, 285 New cases of breast cancer  11, 716 deaths  78% - 10 year survival rates  27% preventable cases  Source:
Pathology Reports Nicole Draper, MD.
NYU Medical Grand Rounds Clinical Vignette Daniel Diaz, MD Class of 2014 September 4, 2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Margin evaluation in Breast Conservation Treatment Dr. C. Gopalakrishnan Nair Department of endocrine Surgery College of Medicine AIMS Kochi, Kerala These.
Female Genital Tract II, Case 2 34-year-old woman presents with a palpable mass in the upper outer quadrant of her left breast. Palpation reveals a distinct,
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
Kevin S. Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Associate Professor of Surgery Harvard.
2/19/2012 دکتر مریم طباطبائیان. E ARLY DETECTION OF BREAST CANCER 2/19/2012 دکتر مریم طباطبائیان.
Kevin S. Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Surgeon The Newton-Wellesley Hospital.
Screening mammography
Pathology.
Kevin S.Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Surgeon The Newton-Wellesley Hospital.
Breast Cancer Dr. Gehan Mohamed. Introduction Most common female cancer. The incidence of breast cancer increases with age. 80% of cases occur in post-menopausal.
Care and Handling of Surgical Specimens
Kevin S.Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Surgeon The Newton-Wellesley Hospital.
W. Scott Campbell, Ph.D., MBA University of Nebraska Medical Center
Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in
De-identification using Harvard Scrubber Umit Topaloglu, Ph.D.
Indications for Breast MR Imaging
Appropriate Sampling of Lumpectomy Specimens
Percutaneous Cryoablation of Metastatic Ovarian Cancer for Local Tumor Control: Improved Patient Survival and Estimated Cost-Effectiveness Brandt P. Currier.
SPECIMEN SONOGRAM - Procedure
Breast Screening and Risk Assessment
Breast Health Katherine B. Lee, MD, FACP April 26, 2018.
Breast Imaging Ravi Adhikary, MD.
Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography  Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,
Current Status of Breast Ultrasound
سرطان الثدي Breast Cancer
Jeong Mi Park, MD, Limin Yang, MD, PhD, Archana Laroia, MD, Edmund A
Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography  Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,
Magnetic Resonance Imaging-guided Breast Biopsies: Tips and Tricks
Avoiding Pitfalls in Mammographic Interpretation
Magnetic Resonance Imaging–Guided Vacuum-Assisted Breast Biopsy: An Initial Experience in a Community Hospital  Paul Friedman, DO, Sean Enis, MD, Jeremy.
Which Way is Up? Policies and Procedures for Surgeons and Pathologists Regarding Resection Specimens of Thymic Malignancy  Frank C. Detterbeck, MD, Cesar.
Marion C.W. Henry, MD Yale University
Presentation transcript:

Using the EHR for the identification of patients at high risk for hereditary breast and ovarian cancer. Brian Drohan University of Massachusetts 5/30/08

Different patterns of disease incidence means different: Risk Factors Analysis Techniques Management Decisions A Glance at Breast Cancer Epidemiology

A Glance at Breast Cancer Risk Models

Techniques for collecting FH data

“…The strengths and weaknesses of the various models described here become apparent as the different output screens are accessed and compared…”

NextExit Mutation Risk ? Risk of Cancer by Age

NextExit Mutation Risk ? Risk of Cancer by Age As her risk of mutation is 10% or greater, and her lifetime risk of breast cancer is 20% or greater, the patient does meet the ACS guidelines for MRI screening. While we will begin MRI screening now, it will be useful to consider genetic testing, which may provide us with sufficient information to possibly stop doing MRI.

NextExit Mutation Risk ? Risk of Cancer by Age

Accession Number: S99X41314 Report Status: Final Type: Surgical Pathology Pathology Report: S99-X41314 OPERATION DATE: 30 AUG 99 ACCESSIONED ON: 30 AUG 99 at 13:15 CLINICAL DATA: Ductal carcinoma in situ with positive margin and residual calcium on outside biopsy. =============================================================================== *** FINAL DIAGNOSIS *** BREAST (LEFT), RE-EXCISION: ATYPICAL DUCTAL HYPERPLASIA, MULTIPLE FOCI, ADJACENT TO BIOPSY CAVITY, AND FOCALLY PRESENT AT MARGINS OF THE SPECIMEN. LOBULAR NEOPLASIA (LOBULAR CARCINOMA IN- SITU). LARGE STROMAL CALCIFICATIONS ADJACENT TO BIOPSY SITE. FIBROCYSTIC CHANGES WITH MICROCALCIFICATIONS. BREAST (LEFT FINAL SHAVED MARGINS): ATYPICAL DUCTAL HYPERPLASIA, SMALL FOCI. Diagnosis by: MARYAM S. MOHAMMADKHANI, MD Signed On: 07 SEP 99 at 09:17 =============================================================================== GROSS DESCRIPTION: Received fresh in the Frozen Section Laboratory, labeled with the patient's name, unit number, and "re-excision left breast," is an ovoid piece of breast tissue, 5.0 X 4.0 X 2.0 cm, the specimen is inked black, the superior margin marked by a short stitch is overinked yellow; the posterior margin, overinked orange; the inferior margin overinked blue. The lateral margin is oriented by the long black stitch. Serial sectioning reveals a biopsy cavity 1.5 X 1.0 X 0.8 cm, surrounded by fibrotic tissue with fat necrosis. This cavity is 0.3 cm from the anterior (closest margin). The remaining breast parenchyma appears grossly unremarkable. Also received is an additional fragment of unremarkable skin- covered fibrofatty tissue measuring 2.2 x 1.5 x 0.8 cm. SECTION CODE A and D: Biopsy cavity with anterior and superior margin. B and C: Biopsy cavity with anterior and inferior margin. E: Representative normal parenchyma (also posterior margin). F: Separate skin-covered fragment. J-M: Additonal sections of biopsy cavity and surrounding parenchyma. Received fresh, labeled with the patient's name, unit number, and "left breast final shaved margin," are unoriented fragments of fibrofatty breast tissue, loosely aggregating to 3.5 X 3.0 X 0.7 cm. Submitted entirely in G-I. Resident: ANUPAMA GUPTA, MD *** INTRA-OPERATIVE DIAGNOSIS *** GROSS DIAGNOSIS, BREAST (LEFT), RE-EXCISION: PREVIOUS BIOPSY SITE: NO LESION GROSSLY SUSPICIOUS. O.R. Resident: VIKRAM DESHPANDE, MD O.R. Diagnosis by: Gunnlaugur P. Nielsen, MD =============================================================================== SOURCE CARE UNIT: SAME DAY SURGICAL UNIT - ACC3 REPORTS TO: Barbara Lynn Smith, M.D. PART A: BREAST (LEFT), RE-EXCISION PART B: BREAST (LEFT FINAL SHAVED MARGINS)

L R Screening Mammogram Diagnostic Mammogram Core Biopsy Showing DCIS

CaGene My Family Health Portrait Jameslink Family Healthware Avon Tablet System Progeny Standards for structured data is essential

Special Thanks Prof. Georges Grinstein John Sharko Christine Lawrence Loura Costello Mary Beth Smirtic Others at IVPR Dr. Kevin Hughes Connie Roche Elissa Ozzane Sherwood Hughes Many more… University of MassachusettsMassachusetts General Hospital